Skip to main content
construction release_alert
Profile editing is temporarily unavailable from June 11-24, 2026 while manual profile data entry transitions to Elements. Learn More.
cancel

A Randomized, Double-Blind, Placebo-Controlled Study To Investigate The Efficacy And Safety Of Carisbamate (Ykp509) As Adjunctive Treatment For Seizures Associated With Lennox-Gastaut Syndrome In Children And Adults, With Optional Open-Label Extensio

Clinical Trial Grant
Duke Scholars

Administered By

Pediatrics, Neurology

Awarded By

SK Life Science, Inc

Start Date

May 1, 2023

End Date

November 28, 2026
 

Administered By

Pediatrics, Neurology

Awarded By

SK Life Science, Inc

Start Date

May 1, 2023

End Date

November 28, 2026